American Capital Management Inc. Has $19.05 Million Stock Holdings in STAAR Surgical (NASDAQ:STAA)

American Capital Management Inc. grew its stake in STAAR Surgical (NASDAQ:STAA - Free Report) by 42.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 512,813 shares of the medical instruments supplier's stock after acquiring an additional 154,037 shares during the period. American Capital Management Inc. owned 1.04% of STAAR Surgical worth $19,051,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Van ECK Associates Corp increased its position in shares of STAAR Surgical by 12.7% during the 3rd quarter. Van ECK Associates Corp now owns 3,478 shares of the medical instruments supplier's stock worth $129,000 after purchasing an additional 393 shares during the last quarter. Sei Investments Co. increased its holdings in STAAR Surgical by 2.7% during the second quarter. Sei Investments Co. now owns 15,087 shares of the medical instruments supplier's stock worth $718,000 after buying an additional 394 shares during the last quarter. Creative Planning increased its holdings in STAAR Surgical by 8.0% during the third quarter. Creative Planning now owns 5,524 shares of the medical instruments supplier's stock worth $205,000 after buying an additional 408 shares during the last quarter. Wealth Enhancement Advisory Services LLC raised its position in STAAR Surgical by 3.8% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 11,343 shares of the medical instruments supplier's stock worth $540,000 after acquiring an additional 418 shares in the last quarter. Finally, Linden Thomas Advisory Services LLC lifted its stake in STAAR Surgical by 2.3% in the second quarter. Linden Thomas Advisory Services LLC now owns 20,721 shares of the medical instruments supplier's stock valued at $987,000 after acquiring an additional 469 shares during the last quarter. Institutional investors and hedge funds own 96.70% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. Canaccord Genuity Group dropped their target price on shares of STAAR Surgical from $41.00 to $31.00 and set a "hold" rating on the stock in a report on Friday, November 1st. Stifel Nicolaus cut their price target on STAAR Surgical from $50.00 to $44.00 and set a "buy" rating for the company in a report on Monday, August 26th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of STAAR Surgical in a report on Thursday, October 31st. One analyst has rated the stock with a sell rating, three have given a hold rating and four have given a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $43.33.

STAAR Surgical Stock Up 3.3 %

Shares of STAA traded up $0.92 during midday trading on Friday, reaching $29.10. 270,007 shares of the stock were exchanged, compared to its average volume of 600,401. The stock's 50 day simple moving average is $30.58 and its 200 day simple moving average is $36.11. The company has a market cap of $1.43 billion, a P/E ratio of 66.14 and a beta of 0.61. STAAR Surgical has a twelve month low of $25.88 and a twelve month high of $52.68.

STAAR Surgical Company Profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.